Myostatin overexpression has been observed in patients with chronic diseases, including cancer, and its dysregulation disrupts protein turnover in skeletal muscle, exacerbating CAC‐related muscle atrophy [7, 8]. The gene discussed is MSTN; the disease is cancer.